Kennedy Capital Management, Inc. Emergent Bio Solutions Inc. Transaction History

Kennedy Capital Management, Inc.

$4.23 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $4.43 Million - $7.9 Million	220,683 New	220,683 $4.63 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $716,739 - $1.02 Million	-12,661 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $3.02 Million - $4.39 Million	-35,078 Reduced 73.48%	12,661 $1.18 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $2.38 Million - $3.35 Million	30,014 Added 169.33%	47,739 $4.28 Million
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $2.29 Million - $3.78 Million	-28,011 Reduced 61.24%	17,725 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $423,339 - $697,539	7,792 Added 20.54%	45,736 $3.62 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $58,566 - $81,618	1,187 Added 3.23%	37,944 $2.2 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $2.55 Million - $2.94 Million	-49,766 Reduced 57.52%	36,757 $1.98 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $61,306 - $86,372	-1,510 Reduced 1.72%	86,523 $4.52 Million
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $107,704 - $145,314	-2,698 Reduced 2.97%	88,033 $4.25 Million
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $201,697 - $276,681	-4,182 Reduced 4.41%	90,731 $4.58 Million
Q4 2018 Feb 12, 2019	SELL	$55.63 - $73.24 $3.21 Million - $4.22 Million	-57,682 Reduced 37.8%	94,913 $5.63 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $955,429 - $1.22 Million	-18,356 Reduced 10.74%	152,595 $10 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $565,605 - $651,154	-11,703 Reduced 6.41%	170,951 $8.63 Million
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $1.84 Million - $2.25 Million	-41,347 Reduced 18.46%	182,654 $9.62 Million
Q4 2017 Feb 13, 2018	SELL	$37.77 - $47.75 $360,363 - $455,582	-9,541 Reduced 4.09%	224,001 $10.4 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $7.97 Million - $9.45 Million	233,542	233,542 $9.45 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account